local_hospital

Cork Radiation Oncology Associates

Address
Radiotherapy Department, Bon Secours Hospital, Western Road, T12 DV56 Cork, Ireland

Cork Radiation Oncology Associates

Cork Radiation Oncology Associates is a specialized center focused on advanced radiation therapy and oncology treatment, with particular expertise in genitourinary malignancies. The center is actively involved in cutting-edge research protocols aimed at improving outcomes for patients with complex cancer presentations requiring multimodal therapeutic approaches.

  • Very high-risk localized prostate cancer management combining radiation therapy with novel hormonal agents
  • Metastasis-free survival optimization through advanced androgen deprivation therapy protocols
  • Integration of next-generation antiandrogen therapies with definitive and salvage radiation treatment strategies

The center demonstrates commitment to evidence-based medicine through participation in international phase 3 clinical trials, specifically investigating the augmentation of standard radiation therapy and androgen deprivation therapy with emerging pharmaceutical agents like darolutamide. This research focus positions Cork Radiation Oncology Associates at the forefront of therapeutic innovation for patients with clinically localized but biologically aggressive prostate cancer, addressing the critical need for improved systemic control in this challenging patient population.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
1
IMP

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
1
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 45 other sites in Ireland

description
Trial volume
1
Outperforms 0% of sites
public
Therapeutic diversity
1areas
Outperforms 0% of sites
groups
Sponsor diversity
1sponsors
Outperforms 0% of sites

Therapeutic Area Benchmark — Ireland

Select a therapeutic area to compare against other sites in Ireland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Ireland

Market Share

Country: Ireland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Cork Radiation Oncology Associates

Trial Sponsor Phase Status Start Date End Date
Evaluation of Darolutamide in Combination with Androgen Deprivation Therapy and Radiation for High-Risk Localized Prostate Cancer: A Phase 3 Randomized TrialCancer Trials IrelandPhase IIINot RecruitingJul 2021

IMP list

IMP Trials Status First start Last start
Darolutamide1Unknown2021-07-202021-07-20

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.